Personal Electronic Health Record
Neurologist

Status w/ Patient: ACTIVE
Gender: Male
Hospital Affiliations: Providence St. Joseph Medical Center-Burbank
Phone: (818) 845-2255
Email:
First Seen: 2024-01-04
| Type | Date | Transcript |
|---|---|---|
Follow-Up | 2024-12-19 | |
New Appointment | 2024-09-25 | |
Follow-Up | 2024-04-08 | |
New Patient | 2024-01-04 |
| Test Name | System | Date | Results | Result Notes | Other Notes | Medicine / Supplments | OG Report File | Facility | Lab Specimin No |
|---|---|---|---|---|---|---|---|---|---|
48 Hrs. Ambulatory EEG | Neurological | 2025-03-18 | Normal | Controlling for Diet, Following Pacing Protocols, Getting Daily Sun, & Doing 40 Min Coherent Breathing | Duloxetine | 20 mg (2024),Methyl B12 | 1000 mcg (2024),Vitamin D3 | 2000 IUs (2024) | ||||
MRI, Brain (With Contrast) | Neurological | 2025-03-14 | Normal | Controlling for Diet, Following Pacing Protocols, Getting Daily Sun, & Doing 40 Min Coherent Breathing | Duloxetine | 20 mg (2024),Methyl B12 | 1000 mcg (2024),Vitamin D3 | 2000 IUs (2024) | ||||
MRI, Standing, Cerebral Spine | Neurological | 2024-11-26 | Abnormal | 1. Reversal of midcervical lordosis.
2. Moderate bilateral neural foramen stenosis at C3-4
3. Mild bilateral neural foramen stenosis at C5/6. | Duloxetine | 20 mg (2024),Methyl B12 | 1000 mcg (2024),Vitamin D3 | 2000 IUs (2024) | ||||
EEG | Neurological | 2024-10-15 | Abnormal | Localized Sharp Wave Activity | Duloxetine | 20 mg (2024),Methyl B12 | 1000 mcg (2024),Vitamin D3 | 2000 IUs (2024) | ||||
Adson's Test | Neurological | 2024-09-25 | Abnormal | Showing Adson's Sign | Duloxetine | 20 mg (2024),Vitamin D3 | 2000 IUs (2024) | ||||
EEG | Neurological | 2024-01-16 | Normal | Vitamin D3 | 4000 IUs (2023) | |||||
MRI, Brain | Neurological | 2024-01-16 | Normal | Vitamin D3 | 4000 IUs (2023) | |||||
Blood Test | General | 2024-01-11 | Normal | Vitamin D3 | 4000 IUs (2023) | Quest | ZD074398V | |||
Sleep Study, Home | Neurological | 2021-09-22 | Normal | Sertraline | 25 mg (2018),Quercetin | 1000 mg (2021),Equilibrant | 1.0 Tablet (2021) |
CONTACT:
Cell: (631) 793-2551
Email: robertjriglietti@tutanota.com